Science Explorer Interactive view Map
Institution · London · United Kingdom

London Cancer

In research, London Cancer stands highest in Medicine (#2,167 of 10,443 worldwide) and Health Sciences (#2,727 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.7× its share of world research.

londoncancer.orgROR OpenAlex
World rank, 2022–2025
#5,441
of 28,054 · #6,571 all time
Rank in United Kingdom
#210
of 1,094
Research works
808
▲ 38% vs 2013–17
Citations
32k
39.8 per fractional work
Top-10% rate
25.9%
record average 16.5%
Open access
56%
world 28%

What is London Cancer known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #2,167 of 10,443 23.7%122 #2665
Health SciencesDomain #2,727 of 11,982 25.4%131 #3298

Each strip is that field’s whole ranked pool, with the notch where London Cancer sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does London Cancer specialise in?

Where its research is concentrated relative to its size: Oncology takes 14.7× the share of its output that it takes of world research.

  1. OncologySubfield · 33.4 works15×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.73× its world share, 40 worksBiochemistry, Geneti…Immunology and Microbiology: 4.35× its world share, 9 worksImmunology and Micro…Neuroscience: 0.39× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.13× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.20× its world share, 1 worksChemistryComputer Science: 0.20× its world share, 3 worksComputer ScienceEngineering: 0.13× its world share, 4 worksEngineeringEnvironmental Science: 0.06× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 1 worksMaterials ScienceMathematics: 0.35× its world share, 1 worksMathematicsPhysics and Astronomy: 0.43× its world share, 2 worksPhysics and AstronomyDentistry: 2.88× its world share, 3 worksDentistryHealth Professions: 1.05× its world share, 6 worksHealth ProfessionsMedicine: 3.15× its world share, 122 worksMedicineNursing: 0.27× its world share, 0 worksNursingVeterinary: 0.10× its world share, 0 worksVeterinaryArts and Humanities: 0.06× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.11× its world share, 1 worksBusiness, Management…Decision Sciences: 0.35× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.75× its world share, 3 worksEconomics, Econometr…Psychology: 0.28× its world share, 2 worksPsychologySocial Sciences: 0.05× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.

Which keywords describe research at London Cancer?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Targeted Therapy, Clinical Trials, Cancer, Cancer Incidence and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy16▲ 11×16 topics
  2. Chemotherapy16▲ 12×21 topics
  3. Epidemiology14▲ 1.73×58 topics
  4. Cancer12▲ 4.6×39 topics
  5. Radiotherapy12▲ 15×13 topics
  6. Targeted Therapy12▲ 26×5 topics
  7. Clinical Trials11▲ 7.8×12 topics
  8. Risk Factors10▲ 4.4×13 topics
  9. Cancer Incidence9▲ 33×4 topics
  10. Prognostic Factors9▲ 10×14 topics
  11. Cancer Immunotherapy9▲ 28×3 topics
  12. Lymphoma9▲ 27×4 topics
  13. Tumor Microenvironment8▲ 8.9×7 topics
  14. Genomic Instability8▲ 35×3 topics
  15. Precision Medicine8▲ 8.0×7 topics
  16. Biomarkers8▲ 5.4×13 topics
  17. Tumor Regression8▲ 34×2 topics
  18. Gene Expression7▲ 5.7×11 topics
  19. Cell-Free DNA7▲ 34×2 topics
  20. Cancer Genomics7▲ 46×1 topic
  21. Mutational Signatures7▲ 46×1 topic
  22. CAR T Cells6▲ 44×1 topic
  23. Chimeric Antigen Receptor6▲ 44×1 topic
  24. Leukemia6▲ 38×2 topics
  25. Health Disparities6▲ 11×5 topics
  26. Population-Based Study6▲ 45×2 topics
  27. Metastasis6▲ 8.6×12 topics
  28. Preventive Services6▲ 50×2 topics
  29. Breast Cancer6▲ 12×11 topics
  30. Cancer Risk6▲ 13×5 topics
  31. Global Surveillance6▲ 59×1 topic
  32. Mortality Rates6▲ 29×1 topic
  33. Human Papillomavirus5▲ 22×3 topics
  34. Genomic Profiling5▲ 24×2 topics
  35. Neoadjuvant Therapy5▲ 9.7×5 topics
  36. Prostate Cancer4▲ 17×5 topics
  37. Immune Checkpoint Blockade4▲ 20×1 topic
  38. Ovarian Cancer4▲ 24×3 topics
  39. PD-1 and PD-L14▲ 20×1 topic
  40. Adjuvant Therapy4▲ 16×2 topics

Which research topics does London Cancer publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, CAR-T cell therapy research, Global Cancer Incidence and Screening and Cancer Immunotherapy and Biomarkers.

Cancer Genomics and Diagnostics: 7 fractional worksCAR-T cell therapy research: 6 fractional worksGlobal Cancer Incidence …6Global Cancer Incidence and Screening: 6 fractional worksCancer Immunotherapy and…4Cancer Immunotherapy and Biomarkers: 4 fractional worksRadiomics and Machine Learning in Medical Imaging: 4 fractional worksLung Cancer Diagnosis and Treatment: 3 fractional worksCervical Cancer and HPV …3Cervical Cancer and HPV Research: 3 fractional worksLung Cancer Treatments and Mutations: 3 fractional worksHead and Neck Cancer Studies: 2 fractional worksProstate Cancer Treatment and Research: 2 fractional works
Cancer ResearchOncologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 7 works
  2. 2 CAR-T cell therapy research Oncology 6 works
  3. 3 Global Cancer Incidence and Screening Oncology 6 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 4 works
  5. 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
  6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
  7. 7 Cervical Cancer and HPV Research Epidemiology 3 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  9. 9 Head and Neck Cancer Studies Otorhinolaryngology 2 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.3%not open43.7%

World: 28% of research is openly available.

with international co-authors50.1%domestic only49.9%

World: 19% is written across borders.

How has London Cancer's research output changed?

Output in 2018–2022 was 38% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.